HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fang Lu Selected Research

Common Cold

4/2022[Acupoint application for exogenous fever: a multi-central retrospective cohort study].
1/2014Chinese proprietary herbal medicine listed in 'China national essential drug list' for common cold: a systematic literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fang Lu Research Topics

Disease

32Neoplasms (Cancer)
09/2021 - 02/2003
11Inflammation (Inflammations)
01/2022 - 08/2012
6Choroidal Neovascularization
03/2022 - 03/2007
6Macular Degeneration (Age-Related Maculopathy)
03/2022 - 03/2007
6Infections
01/2021 - 11/2003
6Parkinson Disease (Parkinson's Disease)
01/2016 - 05/2012
6Myopia
01/2015 - 01/2011
5Fever (Fevers)
04/2022 - 01/2011
5Hemorrhage
01/2021 - 06/2015
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 04/2014
5Breast Neoplasms (Breast Cancer)
11/2019 - 12/2007
4Dyspepsia (Indigestion)
06/2022 - 12/2018
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 12/2017
4Hyperlipidemias (Hyperlipidemia)
01/2022 - 08/2016
4Fibrosis (Cirrhosis)
04/2021 - 03/2007
4Coronary Disease (Coronary Heart Disease)
01/2021 - 01/2015
4Ischemic Stroke
01/2021 - 11/2012
4Gouty Arthritis
11/2019 - 01/2012
4Carcinogenesis
01/2018 - 11/2011
3COVID-19
10/2022 - 10/2020
3Diarrhea
03/2022 - 07/2015
3Vision Disorders (Hemeralopia)
01/2022 - 10/2017
3Hypoxia (Hypoxemia)
01/2022 - 01/2017
3Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 07/2015
3Brain Ischemia (Cerebral Ischemia)
08/2021 - 01/2017
3Infarction (Infarctions)
08/2021 - 11/2012
3Colonic Neoplasms (Colon Cancer)
01/2020 - 09/2012
3Hypertension (High Blood Pressure)
01/2019 - 07/2015
3Hepatocellular Carcinoma (Hepatoma)
01/2017 - 01/2016
2Lymphedema (Milroy Disease)
10/2022 - 01/2022
2Common Cold
04/2022 - 01/2014
2Asthma (Bronchial Asthma)
01/2022 - 03/2012
2Colitis
01/2022 - 01/2021
2Retinoblastoma (Glioblastoma, Retinal)
01/2022 - 03/2010
2Glaucoma
01/2022 - 01/2021
2Retinal Detachment (Retinal Detachments)
12/2021 - 03/2021
2Thrombosis (Thrombus)
12/2021 - 02/2018
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2021 - 01/2021
2Reperfusion Injury
08/2021 - 03/2019
2Stroke (Strokes)
08/2021 - 01/2021
2Liver Diseases (Liver Disease)
04/2021 - 04/2011
2Obstructive Sleep Apnea
01/2021 - 01/2020
2Ischemia
01/2021 - 03/2019
2Fatigue
01/2021 - 07/2015
2Necrosis
01/2021 - 02/2008
2Pain (Aches)
07/2020 - 01/2016
2Rheumatoid Arthritis
06/2020 - 04/2011

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2011
11Proteins (Proteins, Gene)FDA Link
11/2021 - 11/2003
10Pharmaceutical PreparationsIBA
01/2022 - 01/2011
7Therapeutic UsesIBA
01/2022 - 01/2011
7CarbonIBA
11/2021 - 01/2018
7Neuroprotective AgentsIBA
08/2021 - 05/2012
6Messenger RNA (mRNA)IBA
11/2021 - 09/2008
6Retinaldehyde (Retinal)IBA
01/2021 - 03/2009
5CytokinesIBA
01/2022 - 01/2018
5CholesterolIBA
01/2021 - 08/2016
5Estrogens (Estrogen)FDA Link
01/2013 - 06/2007
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2022 - 02/2009
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2021 - 02/2003
4Biological ProductsIBA
04/2021 - 01/2019
4Transcription Factors (Transcription Factor)IBA
01/2021 - 06/2011
4MicroRNAs (MicroRNA)IBA
01/2021 - 11/2008
4SynucleinsIBA
02/2016 - 04/2014
3AcidsIBA
06/2022 - 12/2017
3Hormones (Hormone)IBA
01/2022 - 12/2007
3Interleukin-6 (Interleukin 6)IBA
08/2021 - 01/2021
3Plant ExtractsIBA
01/2021 - 01/2013
3Polysaccharides (Glycans)IBA
04/2016 - 01/2008
3Small Interfering RNA (siRNA)IBA
01/2014 - 06/2006
3Complement Factor H (Factor H)IBA
10/2012 - 09/2010
3DNA (Deoxyribonucleic Acid)IBA
10/2010 - 06/2007
2Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 12/2018
2ChemokinesIBA
01/2022 - 01/2021
2Arginine (L-Arginine)FDA Link
01/2022 - 01/2020
2BilirubinIBA
01/2022 - 01/2019
2Proline (L-Proline)FDA Link
01/2022 - 01/2020
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2021
2Tryptophan (L-Tryptophan)FDA Link
01/2022 - 12/2017
2CateninsIBA
03/2021 - 09/2012
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2021 - 02/2018
2Caspase 3 (Caspase-3)IBA
01/2021 - 05/2019
2ChromatinIBA
01/2021 - 05/2012
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2021 - 07/2015
2Fibrinogen (Factor I)FDA Link
01/2021 - 01/2020
2C-Reactive ProteinIBA
10/2020 - 12/2017

Therapy/Procedure

21Therapeutics
04/2022 - 08/2009
9Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 01/2011
5Drug Therapy (Chemotherapy)
09/2021 - 08/2009
4Lasers (Laser)
03/2022 - 01/2021
3Acupuncture Points (Acupuncture Point)
04/2022 - 03/2012
3Percutaneous Coronary Intervention
01/2022 - 11/2012
3Transplantation
01/2022 - 02/2008
3Light Coagulation
12/2021 - 01/2021
3Intravitreal Injections
01/2021 - 03/2009
3Photochemotherapy (Photodynamic Therapy)
04/2020 - 03/2007
2Radiotherapy
10/2022 - 12/2010
2Stents
12/2021 - 02/2018
2Vitrectomy
03/2021 - 03/2009
2Oral Administration
01/2021 - 01/2021